Search PubMed⌕ Search

Biomedical subjects

D Grob

Publications and source records attributed to D Grob.

At least 145 records · Page 8Linked to original sources

[Reinterventions in postoperative instability of the lumbar spine].

Among the many reasons for reinterventions in the lumbar spine, postoperative instability was chosen as the subject for investigation. Abnormal mobility can be described more precisely in terms of pathological, segmental movement than in terms of instability, as such movement not only represents a greater range of motion of one vertebra towards the adjacent one, but also movement with a restricted (or normal) amplitude of a pathological pattern. Three conditions create pathological postoperative movement: (1) nonunion after attempted fusion; (2) pathologically increased movement because of removal of important weight-bearing structures; (3) compensatory movement of the segment next to a fusion. At the Wilhelm Schulthess Clinic in Zürich, 26 patients underwent one or more operations on the lumbar spine because of persisting pain as a result of postoperative pathological movement. In accordance with the results reported in the literature, good results were rare in reoperations on the lumbar spine (only 8 patients were completely free of pain); 14 patients had intermittent or continuous lumbar pain and 4 patients became worse. The indications for several interventions are carefully analyzed. Better results could probably have been obtained by more stable fixation techniques (transpedicular fixation, combined ventral and dorsal fusions), but the best means of avoiding reoperation is to observe the following guidelines: first, in disectomy cases, the osseous, weight-bearing structures (lamina, facet joint) should remain untouched. If even partial removal seems to be inevitable, fusion should be added done as well.(ABSTRACT TRUNCATED AT 250 WORDS)

Female↗

High-dose intravenous immunoglobulin in the management of myasthenia gravis.

Intravenous immunoglobulin, 400 mg/kg, was administered daily for five days to 12 patients with exacerbation of generalized myasthenia gravis. Degree of weakness, duration of illness, use of prednisone, and history of thymectomy or thymoma did not affect the response to intravenous immunoglobulin. Eleven patients improved, beginning 3.6 +/- 2.7 (mean +/- SD) days after the start of treatment and becoming maximal in 8.6 +/- 4.6 days, with sustained improvement lasting 52 +/- 37 days. Vital capacity increased from 1748 +/- 510 to 2700 +/- 614 mL at peak effect. Decreases in strength occurred in four patients beginning on day 3.2 +/- 2.5, lasted 1.5 +/- 0.6 days, and were mild in three patients. Other effects were minimal. There was no significant change in acetylcholine receptor antibody titers, which were elevated in all patients. Immunoglobulin seemed to produce a more rapid improvement than corticosteroids and is recommended as an adjunct in the management of myasthenia gravis exacerbations.

Adult↗

High-dose intravenous methylprednisolone in myasthenia gravis.

Corticosteroids have been useful in the management of myasthenia gravis (MG), but their efficacy has been limited by the slow onset of improvement, initial worsening of MG, refractoriness of some patients, and side effects of large daily doses. High-dose intravenous methylprednisolone pulses have been reported to produce rapid improvement in several immunologic disorders. In this study we administered 2 g of methylprednisolone intravenously every five days to 15 consecutive patients who had exacerbation of generalized MG. Satisfactory improvement occurred in ten of 15 patients after two courses and in two of five patients after a third course. Onset of improvement began a mean (+/- SD) of 3 +/- 1.1 days after the first infusion, 2.1 +/- 1 days after the second, and 2.4 +/- 1 days after the third, and reached its maximum level 8.9 +/- 6.1 days after the last infusion. A decrease in strength occurred in three patients 1.43 +/- 1.30 days after each infusion, was not marked, and lasted three days, following which improvement generally occurred. Side effects were minimal. After improvement, a daily dose of prednisone (30 mg) was used to maintain improvement. Use of pulse therapy at five-day intervals for the management of severe MG seems to have an advantage in that it produces less initial worsening and more rapid improvement in MG, enabling smaller daily maintenance doses to be employed, with fewer side effects.

Adult↗

Operative treatment of displaced talus fractures.

The talus is a bone with unique biomechanical features and vascular supply. Displaced fractures of the talus, therefore, frequently create problems of proper management. Forty-one severe talar fractures were treated operatively. The incidence of avascular necrosis was relatively low in this series (16%), and all of these were of Type III and IV fractures of the Marti-Weber classification. Type IV fractures were successfully treated by arthrodesis per primam, and suggested that fusion may be the indicated method of treatment in these severe injuries. Fusion of the tibiotalar joint has been used to encourage revascularization and to preserve the important function of the subtalar joint. In all other fracture types with dislocation, anatomic reduction is performed to restore joint congruity and encourage maintenance of talar dome viability. Painstaking postoperative management is important for the complete restoration of function.

Adolescent↗

Urinary incontinence following prostatectomy in patients with myasthenia gravis.

An unusual incidence of urinary incontinence was observed in patients with myasthenia gravis who required transurethral resection of the prostate for relief of obstruction secondary to benign prostatic hypertrophy. This urinary incontinence was not observed in patients who had open prostatectomies (suprapubic and retropubic). The urinary incontinence did not appear to be related to the control of the underlying muscular disorder. It is suggested that the external sphincter in patients with myasthenia gravis may be more vulnerable to thermal changes that occur when a blended current is used during transurethral resection. If prostatectomy is required in a patient with myasthenia gravis, open surgery should be the procedure of choice. If a TURP is used, then a high frequency current is advised with prudent resection in the area of the prostatic apex.

Aged↗

Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.

Neuromuscular transmission was studied in neonatal mice following injection with serum globulin of patients with myasthenia gravis (MG). Compared to controls, these mice showed significant reduction in successive muscle action potentials evoked by repetitive nerve stimulation, amplitude of miniature endplate potentials, and postjunctional sensitivity to acetylcholine. There was no change in evoked isometric tension, quantal content of endplate potentials, or input resistance of the endplate membrane. These results confirm earlier reports of neuromuscular block in animals following injection of globulin of myasthenic patients, and demonstrate that decrease in amplitude of evoked potentials and of miniature endplate potentials is due to reduction in sensitivity to acetylcholine rather than in input resistance of the postsynaptic membrane. These findings are compatible with a postsynaptic defect in MG caused by a humorally mediated autoimmune mechanism.

Adult↗

Desensitization to acetylcholine at motor end plates in normal humans, patients with myasthenia gravis, and experimental models of myasthenia gravis.

Desensitization to ionophoretically applied ACh at the motor end plates of normal humans and patients with MG was studied. The pattern of desensitization at the normal human motor end plate was completely consistent with that observed in muscles of various animals. At motor end plates of MG patients there was greater desensitization and slower recovery from desensitization than in normals. A similar pattern of desensitization was observed at normal end plates when they were exposed to serum globulins of MG patients, and at end plates of muscles from mice than were repeatedly injected with serum globulins of MG patients. Despite the reported reduction in the number of ACh receptors, our calculations show that there is a large pool of spare receptors forming a sizeable margin of safety at the end plates of MG patients. The number of receptors may not show additional progressive reduction in number during repetitive motor activity. Our results indicate that desensitization could play a significant role in the development of neuromuscular block following repetitive motor activity in MG patients. The mechanism by which desensitization is augmented in MG patients in not yet clear.

Acetylcholine↗

Ophthalmoplegia, ptosis, and miosis in temporal arteritis.

Ophthalmoplegia occurred in 7 of 14 patients with biopsy proved temporal arteritis. Only one patient had diplopia. In six of the seven patients, the pattern of ophthalmoplegia did not conform to the distribution of one of the ocular motor nerves. Impairment of upward gaze was most common. In five patients the ophthalmoplegia was accompanied by ptosis, and in five it was accompanied by a miotic pupil. Ophthalmoplegia and ptosis were the major manifestations of temporal arteritis in one patient. Oculomotor signs and symptoms responded to corticosteroid therapy in all seven patients, but in two patients prolonged therapy was necessary. Ophthalmoplegia or ptosis may be early manifestations and may precede visual loss, so that frequent examination is recommended in patients suspected of temporal arteritis, with prompt administration of adequate doses of corticosteroid as soon as any ocular manifestations of temporal arteritis are noted.

Aged↗